Merus N.V., a Utrecht, Netherlands-based oncology-focused biotech company, was acquired for €6.8 billion by Genmab A/S, a Copenhagen, Denmark-based biotechnology firm.
More on SiliconCanals →
Merus N.V., a Utrecht, Netherlands-based oncology-focused biotech company, was acquired for €6.8 billion by Genmab A/S, a Copenhagen, Denmark-based biotechnology firm.
More on SiliconCanals →
Yoga Joint, a Fort Lauderdale, FL-based hot yoga studio chain, raised $5.5...
Timeshifter, a New York-based circadian tech for jet lag, raised an...
Verismo Therapeutics, Inc., a Philadelphia, PA-based CAR-T cell therapy...
Osteoboost Health, a Redwood City, CA-based FDA-cleared bone health...
Clean Slate Clinic, a Sydney-based virtual alcohol detox platform, raised...
Reme-D, a Cairo-based room-temperature PCR test kits company, raised...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.